GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WntResearch AB (XSAT:WNT) » Definitions » Cyclically Adjusted Price-to-FCF

WntResearch AB (XSAT:WNT) Cyclically Adjusted Price-to-FCF : (As of Jun. 04, 2024)


View and export this data going back to 2010. Start your Free Trial

What is WntResearch AB Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


WntResearch AB Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for WntResearch AB's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WntResearch AB Cyclically Adjusted Price-to-FCF Chart

WntResearch AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

WntResearch AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of WntResearch AB's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, WntResearch AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WntResearch AB's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WntResearch AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where WntResearch AB's Cyclically Adjusted Price-to-FCF falls into.



WntResearch AB Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

WntResearch AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, WntResearch AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.68/132.2054*132.2054
=-1.680

Current CPI (Mar. 2024) = 132.2054.

WntResearch AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -21.787 100.432 -28.680
201409 -18.060 100.161 -23.838
201412 -10.895 100.225 -14.371
201503 -7.119 99.950 -9.416
201506 2.928 99.995 3.871
201509 -9.979 100.228 -13.163
201512 -60.595 100.276 -79.890
201603 -9.422 100.751 -12.364
201606 -20.175 101.019 -26.403
201609 -24.195 101.138 -31.627
201612 -21.511 102.022 -27.875
201703 -21.527 102.022 -27.896
201706 -30.772 102.752 -39.593
201709 -39.462 103.279 -50.515
201712 -33.894 103.793 -43.172
201803 -11.610 103.962 -14.764
201806 -10.292 104.875 -12.974
201809 -10.120 105.679 -12.660
201812 -22.665 105.912 -28.292
201903 -25.678 105.886 -32.061
201906 -18.335 106.742 -22.709
201909 -17.299 107.214 -21.331
201912 -21.374 107.766 -26.221
202003 -13.035 106.563 -16.172
202006 -8.672 107.498 -10.665
202009 -5.935 107.635 -7.290
202012 -8.141 108.296 -9.938
202103 -7.672 108.360 -9.360
202106 -3.624 108.928 -4.398
202109 -6.735 110.338 -8.070
202112 -5.341 112.486 -6.277
202203 -7.341 114.825 -8.452
202206 -5.313 118.384 -5.933
202209 -4.431 122.296 -4.790
202212 -5.562 126.365 -5.819
202303 -2.517 127.042 -2.619
202306 -2.460 129.407 -2.513
202309 -1.733 130.224 -1.759
202312 -2.164 131.912 -2.169
202403 -1.680 132.205 -1.680

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


WntResearch AB  (XSAT:WNT) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


WntResearch AB Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of WntResearch AB's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


WntResearch AB (XSAT:WNT) Business Description

Industry
Traded in Other Exchanges
Address
Per Albin Hansson, Road 41, Medeon Science Park, Malmo, SWE, 205 12
WntResearch AB is a cancer research company. The company develops anti-metastatic therapies based on the mechanisms underlying the metastatic process.

WntResearch AB (XSAT:WNT) Headlines

No Headlines